Cardioprotective effects of the novel selective endothelin-A receptor antagonist BSF 461314 in ischemia-reperfusion injury.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 16275532)

Published in J Am Soc Echocardiogr on November 01, 2005

Authors

Alexander Hansen1, Raffi Bekeredjian, Arthur Filusch, David Wolf, Marie-Luise Gross, Sebastian Mueller, Grigorios Korosoglou, Helmut F Kuecherer

Author Affiliations

1: Department of Cardiology, University of Heidelberg, Heidelberg, Germany. alexander_hansen@med.uni-heidelberg.de

Articles by these authors

Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation (2012) 3.30

Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology (2008) 2.76

Knowledge discovery by automated identification and ranking of implicit relationships. Bioinformatics (2004) 2.42

Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest (2013) 2.23

Liver stiffness is directly influenced by central venous pressure. J Hepatol (2009) 2.00

1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol (2003) 1.86

Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension (2010) 1.84

Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol (2012) 1.84

Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors. Cardiovasc Res (2009) 1.67

A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia. Kidney Int (2008) 1.61

Stimulation of the calcium-sensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis. Kidney Int (2011) 1.57

Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci U S A (2006) 1.57

Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Sci Transl Med (2011) 1.54

Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol (2003) 1.54

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol (2012) 1.48

Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol (2009) 1.46

Objective quantification of aortic valvular structures by cardiac computed tomography angiography in patients considered for transcatheter aortic valve implantation. Catheter Cardiovasc Interv (2013) 1.45

Ultrasonic gene and drug delivery to the cardiovascular system. Adv Drug Deliv Rev (2008) 1.45

Evidence of left ventricular contractile asynchrony by echocardiographic phase imaging in patients with type 2 diabetes mellitus and without clinically evident heart disease. Am J Cardiol (2006) 1.44

Early assessment of infarct size and prediction of functional recovery by quantitative myocardial blush grade in patients with acute coronary syndromes treated according to current guidelines. Catheter Cardiovasc Interv (2010) 1.43

Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart (2010) 1.43

Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy. JACC Cardiovasc Imaging (2009) 1.41

Experts and beginners benefit from three-dimensional echocardiography: a multicenter study on the assessment of mitral valve prolapse. J Am Soc Echocardiogr (2013) 1.39

Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol (2003) 1.39

Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart. Stem Cells Dev (2007) 1.25

Hyperferritinaemia-cataract syndrome: worldwide mutations and phenotype of an increasingly diagnosed genetic disorder. Hum Genomics (2010) 1.25

Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc Res (2006) 1.22

The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis. Hepatology (2009) 1.21

Ultrasound targeted microbubble destruction for drug and gene delivery. Expert Opin Drug Deliv (2008) 1.20

Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int (2003) 1.17

Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect. Traffic (2006) 1.17

Microbubbles as ultrasound triggered drug carriers. J Pharm Sci (2009) 1.16

Cellular senescence limits regenerative capacity and allograft survival. J Am Soc Nephrol (2012) 1.11

New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. J Control Release (2010) 1.10

Innovations in phenotyping of mouse models in the German Mouse Clinic. Mamm Genome (2012) 1.09

MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail (2012) 1.09

Reduced reactivation from dormancy but maintained lineage choice of human mesenchymal stem cells with donor age. PLoS One (2011) 1.08

The groin first approach for transcatheter aortic valve implantation: are we pushing the limits for transapical implantation? Clin Res Cardiol (2012) 1.07

Transcriptional analysis of doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol (2005) 1.07

Transcatheter aortic valve implantation after previous mechanical mitral valve replacement: expanding indications? Heart Surg Forum (2011) 1.05

Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology (2009) 1.05

Quantification of atherosclerotic coronary plaque: the missing link between elevated biochemical markers and adverse outcomes in the "vulnerable" patient? J Am Coll Cardiol (2013) 1.05

Arterial calcification in patients with chronic kidney disease. Nephrol Dial Transplant (2009) 1.04

Image quality and radiation dose in 256-slice cardiac computed tomography: comparison of prospective versus retrospective image acquisition protocols. Eur J Radiol (2010) 1.04

Acute outcomes after MitraClip therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry. EuroIntervention (2013) 1.03

Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives. Curr Pharm Des (2012) 1.02

Current experimental perspectives on the clinical progression of alcoholic liver disease. Alcohol Clin Exp Res (2009) 1.02

Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature. J Am Soc Nephrol (2004) 1.01

Prevalence of asymptomatic mitral valve malformations. Clin Res Cardiol (2009) 1.01

An ongoing study of group treatment for men involved in problematic Internet-enabled sexual behavior. Cyberpsychol Behav (2006) 1.00

Melatonin protects kidney grafts from ischemia/reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation. J Pineal Res (2009) 1.00

Reduction of radiation exposure and improvement of image quality with BMI-adapted prospective cardiac computed tomography and iterative reconstruction. Eur J Radiol (2011) 0.99

Heme oxygenase-1 and iron in liver inflammation: a complex alliance. Curr Drug Targets (2010) 0.99

Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination. Am J Physiol Renal Physiol (2008) 0.98

High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy. PLoS One (2011) 0.98

Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med (2007) 0.97

Incidence of late occurring bradyarrhythmias after TAVI with the self-expanding CoreValve(®) aortic bioprosthesis. Clin Res Cardiol (2011) 0.96

Exposing cells to H2O2: a quantitative comparison between continuous low-dose and one-time high-dose treatments. Free Radic Biol Med (2013) 0.95

Transforming growth factor β₁ oppositely regulates the hypertrophic and contractile response to β-adrenergic stimulation in the heart. PLoS One (2011) 0.94

Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice. Am J Physiol Heart Circ Physiol (2010) 0.94

Assessment of global longitudinal strain using standardized myocardial deformation imaging: a modality independent software approach. Clin Res Cardiol (2015) 0.93

Strain-encoded (SENC) magnetic resonance imaging to evaluate regional heterogeneity of myocardial strain in healthy volunteers: Comparison with conventional tagging. J Magn Reson Imaging (2009) 0.93

Impact of systolic and diastolic deformation indexes assessed by strain-encoded imaging to predict persistent severe myocardial dysfunction in patients after acute myocardial infarction at follow-up. J Am Coll Cardiol (2010) 0.93

Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats. Am J Physiol Renal Physiol (2009) 0.93

Hypoxia-inducible factor 1 alpha under rapid enzymatic hypoxia: cells sense decrements of oxygen but not hypoxia per se. Free Radic Biol Med (2008) 0.93

Endogenous endothelin-1 is required for cardiomyocyte survival in vivo. Circulation (2006) 0.93

Analysis of pigmented villonodular synovitis with genome-wide complementary DNA microarray and tissue array technology reveals insight into potential novel therapeutic approaches. Arthritis Rheum (2006) 0.92

Real-time myocardial perfusion imaging for pharmacologic stress testing: added value to single photon emission computed tomography. Am Heart J (2006) 0.92

Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system. PLoS One (2012) 0.92

Comparison of real-time myocardial contrast echocardiography for the assessment of myocardial viability with fluorodeoxyglucose-18 positron emission tomography and dobutamine stress echocardiography. Am J Cardiol (2004) 0.92

Evaluating retinal toxicity of a new heavy intraocular dye, using a model of perfused and isolated retinal cultures of bovine and human origin. Graefes Arch Clin Exp Ophthalmol (2012) 0.92

Single coronary artery with anomalous rising of the right coronary artery: a rare coronary anomaly diagnosed by 256-multidetector computed tomography. Case Rep Med (2011) 0.92

Myocardial left ventricular dysfunction in patients with systemic lupus erythematosus: new insights from tissue Doppler and strain imaging. J Rheumatol (2009) 0.91

Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract. World J Gastroenterol (2010) 0.91

Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats. Nephrol Dial Transplant (2008) 0.91

Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes (2009) 0.91

Classification of diastolic function with phase-contrast cardiac magnetic resonance imaging: validation with echocardiography and age-related reference values. Clin Res Cardiol (2014) 0.91

Long-term preservation of cardiac structure and function after adeno-associated virus serotype 9-mediated microdystrophin gene transfer in mdx mice. Hum Gene Ther (2012) 0.91

Ethanol-mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA-lesions. Int J Cancer (2011) 0.90

Transient micro-elastography: A novel non-invasive approach to measure liver stiffness in mice. World J Gastroenterol (2011) 0.90

Ultrasound-targeted microbubble destruction augments protein delivery into testes. Urology (2007) 0.90

Calcification and cardiovascular problems in renal failure. Kidney Int Suppl (2005) 0.90

Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes. Nephrol Dial Transplant (2009) 0.90

Glucose degradation products result in cardiovascular toxicity in a rat model of renal failure. Perit Dial Int (2010) 0.89

Sustained hydrogen peroxide induces iron uptake by transferrin receptor-1 independent of the iron regulatory protein/iron-responsive element network. J Biol Chem (2007) 0.89

Low-dose growth hormone is cardioprotective in uremia. J Am Soc Nephrol (2008) 0.89

Strain-encoded MRI for evaluation of left ventricular function and transmurality in acute myocardial infarction. Circ Cardiovasc Imaging (2009) 0.89

Cannabinoid receptor type I modulates alcohol-induced liver fibrosis. Mol Med (2011) 0.89

Immediate and chronic effects of AV-delay optimization in patients with cardiac resynchronization therapy. Int J Cardiol (2006) 0.88

Feasibility and clinical benefit of a suture-mediated closure device for femoral vein access after percutaneous edge-to-edge mitral valve repair. EuroIntervention (2015) 0.88

Rapid assessment of longitudinal systolic left ventricular function using speckle tracking of the mitral annulus. Clin Res Cardiol (2011) 0.88

New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization. J Control Release (2010) 0.88